Categorynews

Global Interleukin Inhibitors Market (2020 to 2026) – Featuring AbbVie, AstraZeneca and Sanofi Among Others – ResearchAndMarkets.com

July 23, 2021 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Interleukin Inhibitors Market 2020-2026” report has been added to ResearchAndMarkets.com’s offering.

The global Interleukin Inhibitors market is projected to grow at a modest CAGR of 11.2% during the forecast period (2021-2027).

Companies Mentioned

  • AbbVie, Inc.
  • AstraZeneca Plc
  • Bausch Health Co. Inc.
  • Bristol-Myers Squibb Co.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries, Ltd

The major aspect that drives the growth of the market includes the rising prevalence of various disorders such as arthritis, asthma, eczema, inflammatory bowel disease (IBD), psoriasis, and others across the globe. Some other factors that drive the market growth are the various ongoing clinical trials across the globe. For instance, as per the National Clinical Trial (NCT) Registry, more than 200 clinical trials were going on, as of December 2020, regarding the interleukin inhibitors in the US across different phases of development for various indications. Hence, this is also a major factor that creates a wide scope for the growth of the market over the forecast period.

The global Interleukin Inhibitors market is segmented on the basis of product type and applications. Based on the product type, the market is segmented as IL-1 inhibitors, IL-5 inhibitors, IL-6 inhibitors, IL-17 inhibitors, and IL-23 inhibitors. The IL-17 inhibitors segment is likely to register a significant market value over the forecast period. Based on the applications, the market is segmented as arthritis, asthma, eczema, inflammatory bowel disease (IBD), psoriasis, and others. The psoriasis segment is likely to register a significant market value over the forecast period.

Further, based on the geography, the global Interleukin Inhibitors market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is likely to hold a most substantial share in the market attributing to the presence of the key market giants in the region. Among the region, the US is further estimated to register substantial growth over the forecast period.

Market Segmentation:

1. Global Interleukin Inhibitors Market Research and Analysis by Product Type

2. Global Interleukin Inhibitors Market Research and Analysis by Applications

The Report covers:

  • Comprehensive research methodology of the global Interleukin Inhibitors market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Interleukin Inhibitors market.
  • Insights about market determinants which are stimulating the global Interleukin Inhibitors market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights

3. Competitive Landscape

3.1. Competitive Dashboard

3.2. Key Strategy Analysis

3.3. Key Company Analysis

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Global Interleukin Inhibitors Market by Product Type

5.1.1. IL-1 Inhibitors

5.1.2. IL-5 Inhibitors

5.1.3. IL-6 Inhibitors

5.1.4. IL-17 Inhibitors

5.1.5. IL-23 Inhibitors

5.2. Global Interleukin Inhibitors Market by Application

5.2.1. Arthritis

5.2.2. Asthma

5.2.3. Eczema

5.2.4. Inflammatory Bowel Disease (IBD)

5.2.5. Psoriasis

5.2.6. Others (Transplant Rejection)

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. ASEAN

6.3.5. South Korea

6.3.6. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/5pwarm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900